Where I see patients (2)
The effect of hormonal secretion on survival in adrenocortical carcinoma: A multi-center study.
Survival outcomes for lung neuroendocrine tumors in California differ by sociodemographic factors.
Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
ORR is defined as a complete response (CR) or a partial response (PR) according to RECIST version 1.1 criteria. The All Subjects as Treated (ASaT, ITT) population will be used for analysis which consists of all participants who re...
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
The overall percentage of participants with pathogenic, or likely pathogenic germline mutations will be reported with 95% confidence intervals
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronc...
Will be compared between patients with a bronchial neuroendocrine tumor (NET) receiving lutetium Lu 177 dotatate to those receiving everolimus. The distribution of PFS will be estimated using the Kaplan Meier method. Will be teste...